NCT06467981View on ClinicalTrials.gov

Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)

CompletedOBSERVATIONAL

Enrollment

160

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

February 15, 2025

Conditions

Alzheimer Disease

Interventions

OTHER

Retrospective study

The data from the PET request form will be collected in each center for this population of patients who have had an amyloid PET scan with flutemetamol and the results of the PET examination reports will also be provided, all data will be made anonymous.

Trial Locations (1)

54511

Nuclear medicine department, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT06467981 - Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD) | Biotech Hunter | Biotech Hunter